Breaking News

You are here » Indian-Commodity  :  Top News  :  ICICI Lombard buys 20 lakh shares of JB Chemicals

02-Nov2017

ICICI Lombard buys 20 lakh shares of JB Chemicals

ICICI Lombard General Insurance Company has bought 20 lakh shares of JB Chemicals and Pharmaceuticals at Rs 288 on NSE on November 1, 2017. However, Ashish Dhawan has offloaded 19.52 lakh shares of the company at Rs 288.12 on the NSE on same day.

Earlier, Kotak Mahindra Asset Management Company PM sold 6,00,659 shares of JB Chemicals & Pharmaceuticals at Rs 280 per share on the NSE on October 25, 2017.

JB Chemicals & Pharmaceuticals (JBCPL) is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).



Related News

View all news

Gold futures end higher on Tuesday

Gold futures finished higher on Tuesday, marking biggest single-session percentage rise since November, as investors increased bullion investments amid potential progress on Brexit and trade talks between......

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as speculators reduced exposure on account of reduced export demand in the physical market. Moreover, expectation of higher production due to adequate availability......

Copper futures end higher on weaker dollar

Copper futures ended higher on Tuesday due to a weaker US dollar and hopes that the United States and China would forge a trade deal. A new round of talks between the United States and top metals consumer......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......